June 5, 2009 8K DOC

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PxgY64pTqf62JYjxtttkX6kTW1HwsSm6kaa2VzyDnj5XVYXBbPt+/OtXnnSZprQU 3wfP4XWM+qFCv08U9tNY9w== 0000949699-09-000023.txt : 20090605 0000949699-09-000023.hdr.sgml : 20090605 20090605134725 ACCESSION NUMBER: 0000949699-09-000023 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090602 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20090605 DATE AS OF CHANGE: 20090605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACYCLICS INC CENTRAL INDEX KEY: 0000949699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943148201 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26658 FILM NUMBER: 09876520 BUSINESS ADDRESS: STREET 1: PHARMACYCLICS INC STREET 2: 995 E ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085-4521 BUSINESS PHONE: 408 774 0330 MAIL ADDRESS: STREET 1: PHARMACYCLICS INC STREET 2: 995 E ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085-4521 8-K 1 body8k.htm 8-K June 5, 2009 8K DOC

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

June 2, 2009

(Date of earliest event reported)

PHARMACYCLICS, INC.

(Exact name of registrant as specified in its charter)

Delaware

000-26658

94-3148201

(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer Identification Number)

995 E. Arques Avenue
Sunnyvale, California 94085-4521
(408) 774-0330

(Address of principal executive offices including zip code and registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On June 2, 2009, Pharmacyclics, Inc. received a confirmation from NASDAQ that its application to be transferred from the NASDAQ Global Market to the NASDAQ Capital Market had been approved. On June 4, 2009, Pharmacyclics commenced trading on the NASDAQ Capital Market. The Company has its same ticker symbol "PCYC". The NASDAQ Capital Market is a continuous trading market that operates in the same manner as the NASDAQ Global Market. The Company meets all of the requirements of the NASDAQ Capital Market and adheres to its standards.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:   June 5, 2009

PHARMACYCLICS, INC.
By:           /s/ Rainer M. Erdtmann
Name:   Rainer M. Erdtmann
Title:     Vice President of Finance and Administration and Secretary

GRAPHIC 3 logo.gif LOGO begin 644 logo.gif M1TE&.#EAZP`E`-4_`&>)QH.IU/7X_#EUNG&=SFR9S-GE\M#=[[W1Z#QXO%*& MP]7B\;G.YNSR^)6JURUNMI6UVE6)Q(JMUOS]_D1^OHJBT[+)Y-[H],'4ZOK[ M_3=TN8ZPV&B6R[/"XYJYW'FBT:*SW%N#PGVETDM[O4J!P,K4[/#U^JV\X"EJ MM5R.QM;>\,+,Z*K$XH*<(`B>!OG+AM(VBM$( M`)"U'+A=IDUL;"@W-FM\A(6&AUP7!0,4!VLP/3TW,(.(7!,6`QH)(18T93LO M'1T&>WP6"34)%Y:MKJ]?$Y`//"9"-`21*!:5L%`3.I$:!%`S#24E.3-M`3TU M!4R^TM.^-!\]*`&##`D).J;43P8#D12?5CXN!Z5?-!P]#RRVX?3U;0L4J@R] MU`AX^41`31XB`V``IX,GBUXS;,1T.62&`0E8.12`4'((`W@1ECJ$ MH,-$KYU!LRICZO0F#P\7EAG8@`'#!@-,?P@82%1%B@0:>"RP(J`$!Q0]$E"( MQ+E'@"I#(&5.T+EC@LE$#'`L'6D`XB$OA"GHG(#!CPS!.F[NK.$#"W*E22P5 M@F`W:P7GAF2`0)KU!U.S:_"84>D":0T2UN3(Q3H!@B$"-F`K`,X#-@[S;HG0 MP+H'BV7$C7=^(,'#X0WWB2Q0L'41PA$"5`WQ`0"]9#"'F'1MIHS"J!F0`K. M4*+3BC=L,`@&)&"H&7`OYD#&1@L6$&8D-BR`P0L'F*##FT*8<*$$/]B`P`PE M5-!"#`*21@)"3U@0R0,1;.7##"QH\.(&0UQY*`09^.`#`JD,0]40.KPP@:4^ MF!!!)#R`@V5'!%S@PP0+E$0#:350@)$/&7B`668BJ.'#"X[>P$L3+!A`G:47 MS(@"#*`!.9"&M!;GWJ<_>$#:`]#^,(-YF1FPJ`T8*O""I0($H$$*V@H16ZR" MF$O_0@T#C"&$#1P]H``#U.&6``F"D+'B`RGHZH,!']@PPP5O!K#!"W1&&PD) MMDQ0`@@05P#H"*3QD!%3S:!0@`"#T,##BR*`A@H\=2U9P(L$;&I%`>R-6!![ MP_`S`08#Z3"(#8=^-H0)6/K*#U/OW."C$,W$Z@@1.1R@Y`\CU[``?`:T9O,/ M=D;"P=**'4##&L#`DT)ZC?)KY@\-Y,+O!1<+@<%>/]"`)2UM<4C&88A9`*D0 MFPU`@@,_K'`"#BMT`$(%,H0@**&IG>J!"0+`E\,'-1Q[L01>#]>`0`\LCC0+ M4(DDK3,L7&P!>ZM4)5X-*6SX`\TUD/#/$`>,6H.[0RP`_\,'6/'PP0>;H5"N M#1<*_7-JL`I,]6P#$$`&;N6,;04NV(BPA@D9?[`&"_!0D"YEIW;TP0O@"#%8 M88<-P=X`(D]O"+ M*B*`2P2O,('-U$`'&2D1"2IUO!X,0!M86$`J$O`K_V&I@&0HFP90X+(KZ$`^ M/2"!!53W`S@UX7SIJ\`)5K`#$QR@`_(#P`@VX8$F=.T!'["%"PR0D4RTCE!@ MJD$-XO8#&*2"`E0Q09-J$(&5%/]`00J`SP\VHP$(0"%JL7J=3IJ4P269!V[O MFHT-(U"`'36'B&00```#D+8K*!(",X/9`M80M8LB^UZ@`K]E\7!-R`'F#C0!AES@D`2(1C!BI;(?F.T#Y[B& MT4!E*1=F1P@'.-\!GI`![-$Q.3]8@#,H\,GM#!$"9-C.>90!JBL]X`;N:L`/ M6?#*)Q"`/00P`1^U%*%0%F@X3S`!Y1Z`HM"<9QZH6.86?$`#':S)&1C0XQ.: M,8`YQ,`!)^@`#M9'.,.AKI(_.$`J2``A`1A`!RZJ`0;(,($4HD`"*LO!#XWD MOP0>+5+_+E2:$"#`'A+\S`3:5:23(`"!V7"Q#-@[X1!X&A?MK"@2$>!P]V"0$0.,:AAC M^<"T`A#7*^BRH2&@`QT&E`#^B$/#K$$!#U1%(GBDB@@9>`<*-*<8[K0'=.HE MAP;PR2$.HBY\.&N=3UWL#`O`9P$\<'![4&!4&LSH@3Q@&Q&,4U8D6T#,G%%% M6'$Q1)U2K7J5U"&-YN.E*C3CR0^8\/"<,`$;B"`.`Y+#!Q@`57/!0P$Z2"%G M(K#$!PB@6H`-&C"L>W\:5%!@9B4$/G!_@\JC-M@:P>V=`7WKS]]#$%=FG.<$ M4&7`!@?PUR`$GFR(_UL`^L[!I\K];TOEX`4OH$&_!VV%@?'$`Q+P(Q1R\(X' MV&SA`G#`"N@-\([WG.<$-_C/[3UTCON@U8ZT4F^\*DW M7>DLQX(`ND?_@5HW0<\#^&01!.<">YC]%3D8+K+/SG9KX8PS3RI49@)`Y2'T MR>MMS[L79B!9.A);[VU?#F=Z8Q(63`7I7Z]`"0#/>"[8+B;0;CS;Y2B,[%K= MQBWH@.0WCPZC<]X>.9B2ZXZ.!1-(\?.HQ[?G4Q^.`W2&!/KE0@8JT$76V_[V M]9C9ZV.O!0%(X`2X#[[P8:'[[O)>E03HZ_"7SWQ"&,`X%-#N%ACP`=`V'<2'$`DI>%C"/B`XR<`8F$3#SR`!L<' ,@1B8@1JX@8@0!``[ ` end -----END PRIVACY-ENHANCED MESSAGE-----


	PHARMACYCLICS, INC. By: /s/ Rainer M. Erdtmann Name: Rainer M. Erdtmann Title: Vice President of Finance and Administration and Secretary